检查结果： 1.没有书面评价，这是好的情况； 2.轻微项的483表，或一封感谢信； 3.有批评的483表，它可能会导致：1）Seizure（查封）2）Detention(扣押)3）Restraining Orders and Injunctions(强制停产)4）Penalties（罚款）5）Recall（撤回） 4. Waring letter（警告信）审核重点：对于不同的产品，审核的重点不一样的
化妆品FDA注册 FDA化妆品注册 1/ 化妆品企业注册可以在出口美国之前或者出口之后（30天内）； 2/ 化妆品产品注册需要有1000美金的出口之后，但是实际上FDA无法核对； 3/ Can I file formulations in the VCRP for products that are considered drugs but also have a cosmetic function? 对于药品有化妆品功能的是否可以做化妆品注册？ Yes, products that are considered drugs in the United States, such as sunscreens, but also make cosmetic type claims, such as moisturizing, can be filed in the VCRP. 4/ 可以进行化妆品注册，但是这并不能豁免其需要同时满足药品的相关要求的职责。 办理化妆品的FDA相对来说比较简单，企业提供企业信息以及产品成分表（中英文）就可以了。
FDA 化妆品注册怎么做？ FDA化妆品成分申报 《联邦食品、药品和化妆品法案》(FFDCA)是这样定义”标签”的，所有的标签和其他以书写、印刷和绘制方式随附在药品本身、容器或外包装上的内容，包括包装盒内的资料。术语“随附”并不只限于产品本身，它可延伸到产品的海报、标牌、手册、、广告小册子、宣传册、指南和网页等。 美国对化妆品的成分和标签有严格的法律规定，而且有的化妆品在美国实际上是被划分为药品进行监管的。SUNGO的标签和成分审核服务将通过对美国《联邦法典》、《联邦公报》、VCRP化妆品成分词典、指南性文件、美国FDA标签手册（U.S. FDA Labeling Manual）、警告信等繁杂法规资料的检索和对照，协助企业全方面遵守美国FDA化妆品法规，SUNGO提供以下化妆品标签审核服务： · 一份由我们法规团队对您标签中每一个元素（包括内包装、外包装、网站，等等）审核后准备的详细报告（一般为30-40页）。 · 一份已经修改完成的可以直接印刷的电子图稿。 · 如果同一标签在45天内有变化，我们将免费提供另外的报告和审核修改。 · 如产品销往加州，协助企业完成《加利福尼亚州化妆品安全计划》报告，《加利福尼亚州化妆品安全计划》要求生产商、包装商、经销商确认并列出化妆品标签所有含有已被确定或怀疑会导致、畸形、发育不良或生殖毒性成分的化妆品（包括色素和香料产品）必须向加州政府呈交报告。
FDA对于美国代理人的解释也可以参考看一下网站的原文： Any foreign establishment engaged in the manufacture, preparation, propagation, compounding, or processing of a device imported into the United States must identify a United States agent (U.S. agent) for that establishment. Information about a foreign establishment’s U.S. Agent is submitted electronically using the FDA Unified Registration and Listing System (FURLS system) and is part of the establishment registration process. Each foreign establishment may designate only one U.S. agent. The foreign establishment may also, but is not required to, designate its U.S. agent as its official correspondent. The foreign establishment should provide the name, address, telephone and fax numbers, and e-mail address of the U.S. agent. The U.S. agent identified will be required to complete an automated process to confirm that they have agreed to act as the U.S. agent. The automated process will forward an email verification request to the U.S. agent. They will be re to confirm her/his consent to act as a representative/liaison on behalf of the foreign establishment. If the U.S. agent denies consent (or does not respond within 10 business days), the Official Correspondent/Owner Operator of the foreign establishment will be notified and must designate a new U.S. agent to satisfy the regulatory obligation.